ImmuCell (ICCC) Is At $7.12 Formed Wedge; PRIVATE BANCORP OF AMERICA (PBAM) SI Decreased By 66.67%

ImmuCell Corporation (ICCC) formed wedge down with $6.91 target or 3.00% below today’s $7.12 share price. ImmuCell Corporation (ICCC) has $39.02M valuation. The stock increased 0.14% or $0.01 during the last trading session, reaching $7.12. About 489 shares traded. ImmuCell Corporation (NASDAQ:ICCC) has risen 22.33% since April 22, 2017 and is uptrending. It has outperformed by 10.78% the S&P500.

PRIVATE BANCORP OF AMERICA INC (OTCMKTS:PBAM) had a decrease of 66.67% in short interest. PBAM’s SI was 100 shares in April as released by FINRA. Its down 66.67% from 300 shares previously. With 900 avg volume, 0 days are for PRIVATE BANCORP OF AMERICA INC (OTCMKTS:PBAM)’s short sellers to cover PBAM’s short positions. It closed at $26.65 lastly. It is down 0.00% since April 22, 2017 and is . It has underperformed by 11.55% the S&P500.

Private Bancorp of America, Inc. operates as the bank holding firm for San Diego Private Bank that provides banking services and products to individuals and businesses in California. The company has market cap of $133.59 million. The company's personal banking services include personal checking, personal savings, and retirement accounts; additional services, such as direct deposits, online banking, ATMs/debit cards, credit cards, savings/line of credit overdraft protection, and safe deposit boxes, as well as Deluxe Provent, an integrated suite of identity theft protection services that provides identity theft protection on various fronts comprising prevention, detection, and restoration; and certificate of deposit account registry services. It has a 23.97 P/E ratio. The Company’s business banking services consist of business checking and business savings accounts; and business services comprising treasury management, merchant card, remote deposit capture, and business credit cards.

Investors sentiment decreased to 0.88 in Q4 2017. Its down 2.12, from 3 in 2017Q3. It worsened, as 0 investors sold ImmuCell Corporation shares while 8 reduced holdings. 4 funds opened positions while 3 raised stakes. 678,210 shares or 2.18% more from 663,729 shares in 2017Q3 were reported. Shufro Rose And Lc has invested 0.04% in ImmuCell Corporation (NASDAQ:ICCC). Moreover, Rbf Capital Limited Liability Corporation has 0.01% invested in ImmuCell Corporation (NASDAQ:ICCC) for 13,086 shares. Bancshares Of America De reported 2,032 shares stake. The New York-based Morgan Stanley has invested 0% in ImmuCell Corporation (NASDAQ:ICCC). Wells Fargo Mn has 23,001 shares. Blackrock Inc stated it has 0% in ImmuCell Corporation (NASDAQ:ICCC). Perritt Cap Inc has 0.38% invested in ImmuCell Corporation (NASDAQ:ICCC) for 154,300 shares. Essex Inv Mngmt Communication Ltd Co owns 35,205 shares. Tower Research Capital Ltd Liability Co (Trc) owns 53 shares. Vanguard reported 32,866 shares. Susquehanna Interest Gru Ltd Liability Partnership reported 0% in ImmuCell Corporation (NASDAQ:ICCC). Deutsche Bank & Trust Ag holds 5,300 shares. Moreover, Acadian Asset Mngmt Llc has 0% invested in ImmuCell Corporation (NASDAQ:ICCC) for 1,372 shares. Essex Fincl Service holds 0.05% of its portfolio in ImmuCell Corporation (NASDAQ:ICCC) for 23,776 shares. New York-based Renaissance Tech Ltd Co has invested 0% in ImmuCell Corporation (NASDAQ:ICCC).

ImmuCell Corporation (NASDAQ:ICCC) Institutional Positions Chart